Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Sep. 30, 2022
Current Assets    
Cash and cash equivalents $ 315.1  
Trade receivables, net 334.2 $ 252.9
Receivables from long-term manufacturing contracts, net 299.8 213.3
Inventories, net 588.3 485.6
Prepaid expenses and other current assets 119.9 102.8
Current assets held for sale 0.0 116.1
Total current assets 1,657.3 1,402.9
Property, plant, and equipment, net 295.2 231.9
Operating lease right-of-use assets, net 108.0 87.9
Intangible assets, net 1,112.3 808.0
Goodwill 1,561.2 1,151.1
Other long-term assets 96.5 80.4
Long-term assets held for sale 0.0 105.3
Total Assets 4,830.5 3,867.5
Current Liabilities    
Trade accounts payable 413.0 371.0
Liabilities from long-term manufacturing contracts and advances 390.7 290.3
Current portion of long-term debt 10.0 0.0
Accrued compensation 87.5 97.0
Current liabilities held for sale 0.0 113.8
Other current liabilities 412.6 205.7
Total current liabilities 1,313.8 1,077.8
Long-term debt 1,303.9 1,222.1
Accrued pension and postretirement healthcare 108.0 101.3
Operating lease liabilities 83.2 70.5
Deferred income taxes 297.6 210.2
Other long-term liabilities 57.2 51.8
Long-term liabilities held for sale 0.0 25.8
Total Liabilities 3,163.7 2,759.5
Commitments and contingencies (Note 16)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 69.6 and 68.9 shares outstanding) 0.0 0.0
Additional paid-in capital 704.7 723.8
Retained earnings 1,289.2 812.0
Treasury stock (6.2 and 6.9 shares, at cost) (266.9) (297.3)
Accumulated other comprehensive loss (91.4) (155.6)
Hillenbrand Shareholders’ Equity 1,635.6 1,082.9
Noncontrolling interests 31.2 25.1
Total Shareholders’ Equity 1,666.8 1,108.0
Total Liabilities and Shareholders’ Equity $ 4,830.5 $ 3,867.5